Volume 26 (2023)
Volume 25 (2022)
Volume 24 (2021)
Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
Efficacy and tolerability of needling as an adjuvant to narrowband ultraviolet B therapy in the treatment of vitiligo: a clinical trial

Ebadi Atyeh; Moravvej Hamideh; Hejazi Somayeh; Younespour Shima; Ghalamkarpour Fariba

Volume 16, Issue 3 , 2013, , Pages 89-93

Abstract
  Background: Despite great advances in therapeutic regimens,complete repigmentation in vitiligo is still out of reach. The aimof this assay was to study the efficacy and tolerability of repeatedneedling combined with narrowband ultraviolet B (NBUVB)therapy in the treatment of generalized, stable, refractory ...  Read More

A young woman with multiple hypopigmented patches

Robati Reza; Ebadi Atyeh; Nazari Sajjad; Saffarian Zahra

Volume 14, Issue 3 , 2011, , Pages 117-118

Abstract
  A 33–year-old woman was visited at the dermatological clinic of Loghman-e-Hakim Hospital with multiple hypopigmented patches on her right arm, buttocks and flanks. Her lesions developed over the past year with no regression. Lesions were resistant to multiple antifungal therapies. Clinical examination ...  Read More

Treatment of Severe Alopecia Areata Using Methotrexate as an Adjunctive Drug in Combination with Intravenous and Oral Corticosteroid

Malekzad Farhad; Eshghi Gholamreza; Ebadi Atyeh; Younespour Shima

Volume 13, Issue 3 , 2010, , Pages 91-95

Abstract
  Background: Alopecia areata is one of the most common human autoimmune disorders and its severe types are refractory to all conventional therapies. Corticosteroids have been used in severe alopecia areata since 1950s but there is concern over complications caused by high doses of corticosteroids. Methotrexate ...  Read More